Leveragen logo — Next-Generation Genetic Models for Antibody Discovery

Leveragen

Next-Generation Genetic Models for Antibody Discovery

Founded 2017 United States Woburn, United States 14 employees Biotechnology, Health Care

General Information

Company Name Leveragen
Founded Year 2017
Location United States Woburn, United States
Employees 14
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Leveragen. To contact Leveragen, visit leveragen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Leveragen compare?

A PDF of Leveragen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Leveragen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Leveragen

Leveragen is a Boston-based biotech company with the slogan "Next-Generation Genetic Models for Antibody Discovery". Founded in 2017, Leveragen specializes in genetic engineering, developing comprehensive solutions for genetic modeling and creating designer mutations to study gene function and disease mechanisms. The company is currently focused on engineering next-generation genetic models to enable the discovery of diverse biologic modalities, facilitating the development of novel diagnostics and therapeutics. Leveragen operates in the industries of Biotechnology and Health Care and is headquartered in the United States. As of now, there is no public information available on the last investment or the investors involved in the last investment round.

Business keywords: Biotech, Genetic Engineering, Antibody Discovery, Healthcare Industry, Disease Mechanisms, Biologic Modalities, Therapeutics, Genetic Models, Diagnostic Tools, Forbes Agency Council, ISMPP, CSE, AMWA, Professional Organizations

No funding data available for Leveragen yet.

Leveragen Alternatives & Competitors

Leveragen vs
GENZ Biotechnology
GENZ Biotechnology United Kingdom

Developing novel IVD solutions

Seed
2 employees
AI, Biotechnology
Leveragen vs
Tango Therapeutics
Tango Therapeutics United States

Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medic...

Post-IPO Equity
157 employees
Biotechnology, Health Care

FAQ About Leveragen

Next-Generation Genetic Models for Antibody Discovery
Leveragen was founded in 2017.
Leveragen is headquartered in Woburn, United States.
Leveragen operates in Biotechnology and Health Care. Its work centres on Biotech, Genetic Engineering, Antibody Discovery and Healthcare Industry.
Leveragen has approximately 14 employees.
Top alternatives and competitors to Leveragen include GENZ Biotechnology, Tango Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leveragen and GENZ Biotechnology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Leveragen, https://bouncewatch.com/company/leveragen, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes